Show simple item record

dc.contributor.authorTemmerman, M
dc.contributor.authorDevroey, P
dc.contributor.authorNaaktgeboren, N
dc.contributor.authorAmy, JJ
dc.contributor.authorVan Steirteghem, AC
dc.date.accessioned2013-06-26T13:52:01Z
dc.date.available2013-06-26T13:52:01Z
dc.date.issued1984
dc.identifier.citationActa Eur Fertil. 1984 May-Jun;15(3):179-83en
dc.identifier.urihttp://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/6237540
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/40581
dc.description.abstractThe frequency of the luteinized unruptured follicle (LUF) was determined in a population of 220 regularly cycling women, infertile for at least two years. Laparoscopy was performed during the very first days of the luteal phase. In 26 women without other demonstrable cause of infertility, a diagnosis of LUF was made based on the absence of an ovulation stigma and the low concentrations of progesterone (P) and 17 beta-oestradiol (E2) in peritoneal fluid (PF). Twenty of these 26 women underwent a culdocentesis 72-96 hours after the serum LH-rise in a following cycle. In 19 out of 20, low P and E2 concentrations in PF were again found, suggesting the recurrence of LUF. Subsequently, ovulation was induced with human menopausal gonadotrophins (hMG) alone (n = 4), or in combination with human chorionic gonadotrophin (hCG, n = 9). At carefully timed culdocentesis (at LH/hCG + 72-96 hours), P concentration in PF was high in the hMG-hCG treated women but remained low in those given hMG alone. The combination of hMG and hCG may be a valuable treatment of LUF.en
dc.language.isoenen
dc.titleIncidence, recurrence and treatment of the luteinized unruptured follicle syndrome.en
dc.typeArticleen
local.publisherDepartment of Obstetrics and Gynaecology, College of Health Sciences, University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record